A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses
Australia
2001268452
Filed on 2001-06-15
2001268452
Filed on 2001-06-15
A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses
Canada
2412050
Filed on 2001-06-15
2412050
Filed on 2001-06-15
A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses
European Patent
01946395.9
Filed on 2001-06-15
01946395.9
Filed on 2001-06-15
Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses
US Application 10/297,168
Filed on 2003-07-16
Filed on 2003-07-16
PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES
Australia
2001269762
Filed on 2001-06-08
2001269762
Filed on 2001-06-08
PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES
Canada
2411967
Filed on 2001-06-08
2411967
Filed on 2001-06-08
PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES
Japan
2002-510119
Filed on 2001-06-08
2002-510119
Filed on 2001-06-08
PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES
European Patent
01948294.2
Filed on 2001-06-08
01948294.2
Filed on 2001-06-08
PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES
US Application 10/297,337
Filed on 2002-12-04
Filed on 2002-12-04
Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes
Patent Cooperation Treaty
PCT/US02/33165
Filed on 2002-10-16
PCT/US02/33165
Filed on 2002-10-16